Previous close | 0.5500 |
Open | 0.3700 |
Bid | 0.1000 |
Ask | 2.3000 |
Strike | 17.50 |
Expiry date | 2024-12-20 |
Day's range | 0.2500 - 1.5300 |
Contract range | N/A |
Volume | |
Open interest | 38 |
Evolent Health, Inc. ("Evolent" or "the Company"), (NYSE: EVH) a company focused on achieving better health outcomes for people with complex conditions, today announced it has entered into an agreement to acquire certain assets of Machinify and the exclusive, perpetual and royalty-free license of Machinify Auth, a proven software platform that leverages the latest advances in artificial intelligence to increase the clinical quality, speed and consistency of the clinical reviews for all specialty
Key Insights Evolent Health will host its Annual General Meeting on 6th of June Salary of US$783.3k is part of CEO Seth...
Evolent Health ( NYSE:EVH ) First Quarter 2024 Results Key Financial Results Revenue: US$639.7m (up 50% from 1Q 2023...